Dora Mitchell, PhD
Before joining Interius, Dora served as Vice President of Business Development and Vice President of Operations of Carisma Therapeutics, where she was on the founding team. Prior to the launch of Carisma, she managed a portfolio of 60 start-up companies at PCI Ventures at the University of Pennsylvania as Director of the UPstart Company Incubator, often acting as “entrepreneur-in-residence” for companies in the life sciences portfolio. Dora has held roles spanning preclinical, early clinical, management, and board positions in young companies, including NellOne Therapeutics, Cognizance Biomarkers (acquired), CytoVas, LignaMed, Linnaeus Therapeutics Inc., Quantitative Radiology Solutions, and Ophidion, Inc.
Dora fell in love with early-stage companies as a member of the Health and Life Sciences team at Battelle Ventures, LP, an early-stage life sciences and technology venture capital fund. She serves as a founding investment committee member of Nassau Street Ventures. Dora holds a PhD in molecular biology from Princeton University.